glp-1 coverage news employer today GLP-1 Drugs: 2025 Pulse Survey (U.S.) Medicaid Coverage of and Spending

With incretin-based drugs, much of the reported lean mass loss may not be skeletal muscle, but some is

Within months of GLP-1 prescriptions written for obesity and overweight, JP Morgan analysts wrote an influential report on the drug category and implications for the health care industryand other sectors, notably food and beverage consumption

For complete coverage of all related areas of Endocrinology, please visit our on-line FREE web-text, WWW.ENDOTEXT.ORG.

Starting at $149 monthly, these medications provide the same active ingredient with pharmacist-guided precision do

GoodRx reports that while satisfaction with GLP-1s for weight loss is high, costs and access issues significantly impact patient experiences.

Our blog series on GLP-1 agonists for weight loss is aimed at unpacking the science behind this new frontier in weight management, presenting a detailed overview of how they work, their efficacy, and their role in a holistic approach to health and wellness.